AHCY and esophageal squamous cell carcinoma: Our study elucidates a previously unrecognized oncogenic signaling axis in esophageal squamous cell carcinoma whereby the co‐chaperone STIP1 and metabolic enzyme AHCY are co‐opted to drive upregulation of the Warburg effect and promote ESCC progression.